Backstrom Jay T.
SEC insider (Form 3/4/5 filer). CIK 0001796398. Director at AGIOS PHARMACEUTICALS, INC. (AGIO) and 2 other issuers. 11 reported Form 4/5 transactions since Sep 2024; latest on Jul 8, 2026. Located in CAMBRIDGE, MA.
Companies Backstrom Jay T. has filed insider reports for
- AGIOS PHARMACEUTICALS, INC. (AGIO): Director
- LAVA Therapeutics NV (LVTX): Director
- Scholar Rock Holding Corp (SRRK): Director, Officer, CHIEF EXECUTIVE OFFICER
Backstrom Jay T.
CIK: 0001796398
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jul 8, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirectRestricted stock units
1.4K shares- - Jul 8, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirect1.4K shares- - Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectStock options (right to buy)
15K shares- - Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectRestricted stock units
2.9K shares- - Nov 13, 2025LVTX
LAVA Therapeutics NV
DispositionDirectShare Options (Right to Buy)
33.4K shares- - Jul 8, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectRestricted stock units
4.3K shares- - Jul 8, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectStock options (right to buy)
23.4K shares- - Mar 10, 2025SRRK
Scholar Rock Holding Corp
AwardDirect113.6K shares- - Feb 18, 2025SRRK
Scholar Rock Holding Corp
SaleDirect18.4K shares at avg. $36.83$677K - Feb 13, 2025LVTX
LAVA Therapeutics NV
AwardDirectCommon Shares (Right to Buy)
33.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 8, 2026 |  AGIO AGIOS PHARMACEUTICALS, INC. | Exercise Restricted stock units | 1,447 | - | - | Direct |
| Jul 8, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award | 1,447 | - | $0 | Direct |
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Stock options (right to buy) | 14,950 | - | - | Direct |
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Restricted stock units | 2,927 | - | - | Direct |
| Nov 13, 2025 |  LVTX LAVA Therapeutics NV | Disposition Share Options (Right to Buy) | 33,390 | - | - | Direct |
| Jul 8, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Restricted stock units | 4,341 | - | - | Direct |
| Jul 8, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Stock options (right to buy) | 23,393 | - | - | Direct |
| Mar 10, 2025 |  SRRK Scholar Rock Holding Corp | Award | 113,570 | - | - | Direct |
| Feb 18, 2025 | SRRK Scholar Rock Holding Corp | Sale | 18,372 | $36.83 | $676,622 | Direct |
| Feb 13, 2025 | LVTX LAVA Therapeutics NV | Award Common Shares (Right to Buy) | 33,390 | - | - | Direct |
1-10 of 11 transactions